Yuheng Pharmaceutical announced that the company's director, general manager and financial director Guo Leifeng, deputy general managers Li Runbao, Wang Xiaohang, and director, deputy general manager and board secretary Liu Yueyin plan to reduce their total holdings by no more than 11.579 million shares through centralized bidding within 3 months after 15 trading days from the date of disclosure of the announcement, accounting for 0.5189% of the company's total share capital. Among them, Guo Leifeng plans to reduce his holdings by no more than 10.495 million shares, accounting for 0.4707% of the company's total share capital. The reason for this holdings reduction is due to personal capital requirements. The holdings reduction period is from October 15, 2026 to January 14, 2027. The implementation of this holdings reduction plan will not result in a change in the company's control.

Yuheng Pharmaceutical announced that the company's director, general manager and financial director Guo Leifeng, deputy general managers Li Runbao, Wang Xiaohang, and director, deputy general manager and board secretary Liu Yueyin plan to reduce their total holdings by no more than 11.579 million shares through centralized bidding within 3 months after 15 trading days from the date of disclosure of the announcement, accounting for 0.5189% of the company's total share capital. Among them, Guo Leifeng plans to reduce his holdings by no more than 10.495 million shares, accounting for 0.4707% of the company's total share capital. The reason for this holdings reduction is due to personal capital requirements. The holdings reduction period is from October 15, 2026 to January 14, 2027. The implementation of this holdings reduction plan will not result in a change in the company's control.